German Pharmacy Drug Sales Up

21 July 1996

Drug sales in German pharmacies rose 7.1% in the first five months of 1996 to reach 10.2 billion Deutschemarks ($6.63 billion), reports the drug industry association, the BPI. The rise in western Germany was 6.6% and that in the eastern states was 9.2%.

Drug specialty prices in the reporting period went up 1.4%, with prices of pharmacy drugs up 2% and those of hospital drugs falling 1.4%. Volume accounted for 4.6% of the rise in sales, with price rises accounting for only 0.3% of growth.

The main reason for the increase during January-May was a wave of colds and flu, which started in 1995. Respiratory system drugs benefited in particular from this wave, increasing sales by 9.5%. Sales of anti-infectives increased 10.9% and central nervous system treatment sales were up 11.3%.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight